The estimated Net Worth of William A. Backus is at least $7.39 Million dollars as of 30 July 2024. Mr. Backus owns over 4,804 units of Balchem stock worth over $21,644 and over the last 13 years he sold BCPC stock worth over $6,412,043. In addition, he makes $960,135 as Chief Accounting Officer at Balchem.
Sign up
Mr. Backus BCPC stock SEC Form 4 insiders trading
William has made over 9 trades of the Balchem stock since 2011, according to the Form 4 filled with the SEC. Most recently he sold 4,804 units of BCPC stock worth $859,580 on 30 July 2024.
The largest trade he's ever made was exercising 48,500 units of Balchem stock on 13 March 2017 worth over $1,919,145. On average, William trades about 4,279 units every 132 days since 2011. As of 30 July 2024 he still owns at least 132 units of Balchem stock.
You can see the complete history of Mr. Backus stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
William Backus biography
William A. Backus CPA serves as Chief Accounting Officer of the Company. Mr. Backus has been the Company’s Chief Accounting Officer since October 2017. Prior to that, Mr. Backus was the Company’s Chief Financial Officer and Treasurer from June 2014 to October 2017. He was Chief Accounting Officer and Assistant Treasurer of the Company from June 2011 to June 2014 and was Controller of the Company from January 2006 to June 2011. He was Controller of Stewart EFI, LLC, a precision metal component manufacturer, from 1999 through 2005.
What is the salary of William Backus?
As the Chief Accounting Officer of Balchem, the total compensation of William Backus at Balchem is $960,135. There are 4 executives at Balchem getting paid more, with Theodore Harris having the highest compensation of $3,808,410.
How old is William Backus?
William Backus is 53, he's been the Chief Accounting Officer of Balchem since 2019. There are 9 older and 2 younger executives at Balchem. The oldest executive at Balchem Corp. is Perry Premdas, 67, who is the Independent Director.
What's William Backus's mailing address?
William's mailing address filed with the SEC is C/O BALCHEM CORPORATION, 5 PARAGON DRIVE, MONTVALE, NJ, 07645.
Insiders trading at Balchem
Over the last 21 years, insiders at Balchem have traded over $37,143,279 worth of Balchem stock and bought 47,350 units worth $1,702,145 . The most active insiders traders include Dino A Rossi, Frank Fitzpatrick, and David F Ludwig. On average, Balchem executives and independent directors trade stock every 36 days with the average trade being worth of $2,396,094. The most recent stock trade was executed by Gunsteren Job Leonard Van on 31 July 2024, trading 7,750 units of BCPC stock currently worth $462,288.
What does Balchem do?
founded in 1967, balchem provides state-of-the-art solutions and the finest quality products for a range of industries worldwide. our company consists of four business segments: human nutrition & health; specialty products; animal nutrition and health and industrial products. balchem employs approximately 1,000 people worldwide who are engaged in many diverse activities, developing our company into chosen market leadership positions. visit our website at www.balchem.com to learn more about us and the exciting opportunities we have available!
What does Balchem's logo look like?
Complete history of Mr. Backus stock trades at Balchem
Balchem executives and stock owners
Balchem executives and other stock owners filed with the SEC include:
-
Theodore Harris,
Chairman of the Board, President, Chief Executive Officer -
Theodore L. Harris,
Chairman, CEO & Pres -
Martin Bengtsson,
Chief Financial Officer -
Scott Mason,
Vice President of Manufacturing and Supply Chain and Vice President and General Manager, Industrial Products -
William Backus,
Chief Accounting Officer -
Mark Stach,
General Counsel, Secretary -
Carl Martin Bengtsson,
CFO & Treasurer -
James C. Hyde,
Sr. VP and GM of Human Nutrition & Health -
Mark A. Stach,
Gen. Counsel & Corp. Sec. -
John Televantos,
Lead Independent Director -
Daniel Knutson,
Independent Director -
Matthew Wineinger,
Independent Director -
Perry Premdas,
Independent Director -
David Fischer,
Independent Director -
Paul Coombs,
Independent Director -
Joyce Lee,
Independent Director -
Dino A Rossi,
President and CEO -
Edward Mcmillan,
Director -
Matthew David Houston,
General Counsel, Secretary -
Frank Fitzpatrick,
Corp Controller & Treasurer -
Mary Theresa Coelho,
Chief Financial Officer -
Monica Vicente,
-
Olivier Rigaud,
-
Elaine R Wedral,
Director -
Richard Allen Bendure,
Chief Operating Officer -
Francis X Mcdermott,
Director -
Paul H Richardson,
VP Research and Development -
Dana E. Putnam,
VP and General Manager -
Cruce Patricia Siuta,
Vice President Technology -
Israel Sheinberg,
Director -
Winston A Samuels,
Vice President/GM Encapsulates -
Hoyt Jr Ammidon,
Director -
Kenneth P Mitchell,
Director -
Robert T Miniger,
VP/Human Resources -
David F Ludwig,
Vice President -
James C Hyde,
Sr. Vice President -
Kathleen B Fish,
-
Frederic Boned,
SVP/GM, Human Nutri. & Health -
Martin Luther Reid,
SVP Chief Supply Chain Officer -
Hatsuki Miyata,
EVP, Gen. Counsel & Secretary -
Gunsteren Job Leonard Van,
SVP and GM, Specialty Products -
Michael Robert Sestrick,
SVP & Chief Technology Officer -
Michael Brent Tignor,
SVP & Chief HR Officer -
Jonathan Harrison Griffin,
SVP & GM, Animal Nutrition